Cargando...

Cardiotoxicity from immune checkpoint inhibitors

Immune checkpoint inhibitor (ICI) therapy has greatly improved treatment of various advanced cancers but increasing use of ICI therapy has exposed the risk of ICI-related cardiovascular side effects. Immune checkpoints are inhibitory regulators of T cell activation and mediate T cell effector functi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Cardiol Heart Vasc
Main Authors: Michel, Lars, Rassaf, Tienush, Totzeck, Matthias
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736791/
https://ncbi.nlm.nih.gov/pubmed/31517036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2019.100420
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!